Susquehanna International Group’s Marker Therapeutics MRKR Stock Holding History

Susquehanna International Group’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,170	Closed	-$121K	–	13612
2021 Q3	$121K	Sell	7,170 -640	-8%	-$13.1K	﹤0.01%	11941
2021 Q2	$218K	Sell	7,810 -10,020	-56%	-$264K	﹤0.01%	11420
2021 Q1	$399K	Buy	+17,830	New	+$408K	﹤0.01%	9993
2020 Q2	–	Sell	-1,260	Closed	-$24K	–	10619
2020 Q1	$24K	Sell	1,260 -2,670	-68%	-$68K	﹤0.01%	9894
2019 Q4	$113K	Sell	3,930 -4,110	-51%	-$150K	﹤0.01%	9086
2019 Q3	$411K	Buy	8,040 +2,970	+59%	+$176K	﹤0.01%	7695
2019 Q2	$402K	Buy	5,070 +3,340	+193%	+$198K	﹤0.01%	7726
2019 Q1	$114K	Buy	+1,730	New	+$101K	﹤0.01%	8193

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group's MRKR Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Marker Therapeutics (MRKR) in Q1 2026: 48,780 shares worth $63.4K. The stake represents ﹤0.01% of the portfolio and ranks #12553 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in MRKR as recently as Q2 2025.

Susquehanna International Group first reported a position in MRKR in Q4 2018 and has held it in 19 quarters since. The position peaked at $505K in Q1 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

Susquehanna International Group held 48,780 shares of Marker Therapeutics worth $63.4K as of Q1 2026.
Marker Therapeutics was a new Susquehanna International Group position in Q1 2026.
Marker Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12553 holding.
Susquehanna International Group first reported a position in Marker Therapeutics in Q4 2018 and has held it in 19 quarters since.
Susquehanna International Group's Marker Therapeutics position peaked at $505K in Q1 2019.
35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.